Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Short term Debt: 2020-2024

Historic Short term Debt for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Dec 2024 value amounting to $5.4 million.

  • Maravai Lifesciences Holdings' Short term Debt changed negligibly% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $5.4 million for FY2024, which is negligibly% changed negligibly from last year.
  • Per Maravai Lifesciences Holdings' latest filing, its Short term Debt stood at $5.4 million for FY2024, which was down 0.00% from $5.4 million recorded in FY2023.
  • In the past 5 years, Maravai Lifesciences Holdings' Short term Debt ranged from a high of $34.8 million in FY2021 and a low of $5.4 million during FY2022.
  • For the 3-year period, Maravai Lifesciences Holdings' Short term Debt averaged around $5.4 million, with its median value being $5.4 million (2024).
  • In the last 5 years, Maravai Lifesciences Holdings' Short term Debt skyrocketed by 480.63% in 2021 and then tumbled by 84.38% in 2022.
  • Yearly analysis of 5 years shows Maravai Lifesciences Holdings' Short term Debt stood at $6.0 million in 2020, then spiked by 480.63% to $34.8 million in 2021, then slumped by 84.38% to $5.4 million in 2022, then remained steady at $5.4 million in 2023, then remained steady at $5.4 million in 2024.